Fresenius SE KGaA (XSWX:FRE) Asset Impairment Charge: CHF0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:FRE Fresenius SE & Co KGaA XSWX:FRE
74 GF Score
Price CHF39.27
GF Value CHF34.38
! 5 Warning Signs
View Full Analysis

What is Fresenius SE KGaA Asset Impairment Charge?

Fresenius SE KGaA XSWX:FRE 74 Asset Impairment Charge is CHF0 Mil as of Mar. 2026. GuruFocus rates XSWX:FRE with a GF Score™ of 74/100 and a GF Value™ of CHF34.38. The stock has 5 warning signs investors should review.

Fresenius SE KGaA's Asset Impairment Charge for the three months ended in Mar. 2026 was CHF0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2026 was CHF0 Mil.

Fresenius SE KGaA Asset Impairment Charge Related Terms

Fresenius SE KGaA Asset Impairment Charge Historical Data

* Premium members only.

The historical data trend for Fresenius SE KGaA's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA Asset Impairment Charge Chart

Fresenius SE KGaA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fresenius SE KGaA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
XSWX:FRE
74GF Score
Fresenius SE & Co KGaA XSWX:FRE
Asset Impairment Charge is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fresenius SE KGaA Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0 Mil.

What does a Asset Impairment Charge of CHF0 Mil mean?
Fresenius SE KGaA (XSWX:FRE) has a Asset Impairment Charge of CHF0 Mil as of Mar. 2026.
Is Fresenius SE KGaA's Asset Impairment Charge too high?
Fresenius SE KGaA's current Asset Impairment Charge is CHF0 Mil. Overall, Fresenius SE KGaA has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Fresenius SE KGaA's Asset Impairment Charge compare to HCA and THC?
Fresenius SE KGaA's Asset Impairment Charge of CHF0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Impairment Charge for a Healthcare Providers & Services company?
A good Asset Impairment Charge depends on the Healthcare Providers & Services industry context. However, Asset Impairment Charge should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Impairment Charge mean?
A high Asset Impairment Charge can signal that a stock is expensive relative to its fundamentals. Fresenius SE KGaA's current Asset Impairment Charge is CHF0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius SE KGaA stock overvalued right now?
Fresenius SE KGaA (XSWX:FRE) has a current Asset Impairment Charge of CHF0 Mil. The stock's GF Value™ is CHF34.38, compared to a current price of CHF39.27 — trading 14.2% above its estimated fair value. The current Asset Impairment Charge is CHF0 Mil. Fresenius SE KGaA's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Impairment Charge calculated?
Asset Impairment Charge is calculated from a company's financial statements. For Fresenius SE KGaA (XSWX:FRE), the current Asset Impairment Charge is CHF0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fresenius SE KGaA (XSWX:FRE) Overvalued in 2026?

Based on GuruFocus' analysis, Fresenius SE KGaA stock appears to be overvalued. The current stock price of CHF39.27 is trading 14.2% above its estimated GF Value™ of CHF34.38.

Key valuation signals for XSWX:FRE:

  • Asset Impairment Charge: CHF0 Mil
  • GF Value™: CHF34.38 vs. price of CHF39.27 (14.2% above fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the XSWX:FRE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fresenius SE KGaA Business Description

Address Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius is a healthcare holding company based in Germany. The company owns a minority stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals primarily in Germany and Spain.
74GF Score

Get the complete analysis for XSWX:FRE

Asset Impairment Charge is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF39.27
Price
CHF34.38
GF Value